| 2011 |
ARHGAP18 functions as a GTPase-activating protein (GAP) for RhoA; overexpression suppresses RhoA activity and disrupts stress fiber formation, while siRNA knockdown enhances stress fiber formation and sustained RhoA activation upon cell attachment. ARHGAP18 localizes to the leading edge during cell spreading and migration and is required for cell polarization. |
Overexpression/siRNA knockdown, RhoA activity assays, immunofluorescence, cell spreading/migration assays |
Molecular biology of the cell |
High |
21865595
|
| 2013 |
The Drosophila ARHGAP18 orthologue Conundrum (Conu) interacts with Moesin (an ERM protein), which recruits Conu to the cell cortex to negatively regulate RhoA activity; cortically localized Conu promotes cell proliferation in a RhoGAP-activity-dependent manner, and this growth function also requires increased Rac activity. |
Genetic interaction, Co-IP/pulldown, cell cortex localization assays, epistasis in Drosophila |
Molecular biology of the cell |
High |
23468526
|
| 2014 |
ARHGAP18 acts specifically on RhoC (not RhoA) in endothelial cells to suppress tip cell behavior and stabilize junctions; loss of ARHGAP18 promotes endothelial hypersprouting in zebrafish and murine retinal vessels. ARHGAP18 relocalizes to angiogenic/destabilized EC junctions in a ROCK-dependent manner, suppressing tip cell genes Dll4, Flk-1, and Flt-4. |
siRNA knockdown, ARHGAP18-knockout mice, zebrafish genetics, immunofluorescence, tumor vascularization assays |
Small GTPases |
High |
25425145
|
| 2017 |
ARHGAP18 localizes to microtubules in endothelial cells (confirmed by structured illumination, GSD, and TIRF microscopy, plus biochemical fractionation); ARHGAP18 depletion destabilizes microtubules (reduced acetylated α-tubulin and glu-tubulin), impairing endothelin-1 secretion and neutrophil transmigration. Microtubule stabilization by ARHGAP18 requires its GAP activity and is rescued by ROCK and HDAC6 inhibition. Thrombin enhances the plasma membrane-bound fraction of ARHGAP18. |
SIM/GSD/TIRF microscopy, biochemical fractionation, siRNA knockdown, ARHGAP18-KO mouse endothelial cells, GAP-mutant rescue experiments |
Molecular biology of the cell |
High |
28251925
|
| 2017 |
miR-200b directly downregulates ARHGAP18 in triple-negative breast cancer cells; enforced miR-200b expression activates RhoA, increases focal adhesions and stress fibers, and reduces migration/metastasis. Overexpression of ARHGAP18 in miR-200b-expressing cells reduces RhoA activity and restores migration, and ROCK inhibition phenocopies miR-200b effects, placing ARHGAP18 upstream of ROCK in this axis. |
miR-200b overexpression/ARHGAP18 KO, RhoA activity assays, cell migration assays, ROCK inhibitor pharmacology, in vivo metastasis assays |
Cancer research |
High |
28619708
|
| 2017 |
In smooth muscle cells, ARHGAP18 deficiency (global KO mice) leads to a synthetic/proinflammatory phenotype with H3K4me3 enrichment and H3K27me3 depletion at MMP2 and TNF-α promoters, and loss of Akt activation; mTORC1 inhibitor rapamycin partially rescues the abnormal SMC phenotype. ARHGAP18 KO mice develop thoracic aortic aneurysm with increased frequency upon angiotensin II challenge. |
Arhgap18-/- mice, ChIP for histone marks, rapamycin pharmacological rescue, angiotensin II challenge |
Circulation research |
High |
28701309
|
| 2017 |
LARG GEF and ARHGAP18 coordinately control RhoA activity in mesenchymal stem cells to determine lineage fate: ARHGAP18 knockdown increases basal RhoA activity, actin stress fibers, suppresses adipogenesis, and enhances osteogenic commitment (alkaline phosphatase, Sp7/Alpl/Bglap). ARHGAP18 provides tonic RhoA inhibition in static conditions, whereas LARG mediates mechanical strain-induced RhoA activation. |
siRNA knockdown, RhoA activity assays (G-LISA), Oil-Red-O staining, alkaline phosphatase staining, qPCR of lineage markers, mechanical strain experiments |
Bone |
High |
29208526
|
| 2018 |
IP3R3 silencing in breast cancer cells decreases ARHGAP18 expression and reduces RhoA activity (G-LISA), Cdc42, and Y861-FAK phosphorylation, placing ARHGAP18 downstream of IP3R3 in the IP3R3/ARHGAP18/RhoA/mDia1/FAK pathway that controls actin cytoskeletal organization and cell morphology. |
siRNA knockdown of IP3R3, RhoA G-LISA activity assay, Western blot for ARHGAP18/FAK phosphorylation, immunofluorescence |
Biochimica et biophysica acta. Molecular cell research |
Medium |
29630900
|
| 2019 |
ARHGAP18 is a flow-responsive gene in endothelial cells; its depletion inhibits EC alignment in the direction of laminar flow, promotes NF-κB activation, disrupts junctions, increases ICAM-1, and decreases eNOS. ApoE-/- Arhgap18-/- double-KO mice on high-fat diet develop early-onset atherosclerosis in atheroprotected regions. |
siRNA depletion, laminar flow chamber assays, ApoE/Arhgap18 double-KO mouse atherosclerosis model, immunofluorescence for NF-κB/ICAM-1/eNOS |
Journal of the American Heart Association |
High |
30630384
|
| 2020 |
YAP is downstream of ARHGAP18 in mature endothelial cells under laminar shear stress: ARHGAP18 depletion decreases YAP expression but causes its nuclear localization (activation) and disrupts VE-Cadherin at junctions; ARHGAP18 overexpression upregulates YAP, promotes its phosphorylation (inactivation), and decreases the YAP target gene Cyr61. This ARHGAP18-YAP axis is required for atheroprotective EC alignment. |
siRNA depletion, ARHGAP18 overexpression, confocal imaging of YAP nuclear localization, Cyr61 reporter, ARHGAP18-KO mouse in vivo imaging |
Cell communication and signaling : CCS |
Medium |
32013974
|
| 2020 |
PKN3 (a serine/threonine kinase) phosphorylates ARHGAP18 in vitro; the interaction between PKN3 and ARHGAP18 is mediated via the N-terminal part of ARHGAP18, is enhanced upon ARHGAP18 phosphorylation, and PKN3-mediated phosphorylation of ARHGAP18 enhances its GAP domain activity to further reduce active RhoA levels. |
Phosphoproteomic screen with analog-sensitive PKN3, in vitro kinase assay, Co-IP, GAP domain activity assay, RhoA activity measurement |
International journal of molecular sciences |
High |
33092266
|
| 2021 |
ATG16L1 knockdown (autophagy impairment) causes accumulation of SQSTM1/p62 and ARHGAP18 protein, leading to decreased RhoA activity and impaired epithelial cell migration; thiopurines reverse this effect. ARHGAP18 accumulation appears mediated by impaired autophagic degradation and observed in human Crohn's disease tissue. |
Lentiviral ATG16L1/ATG5 KD, G-LISA for RhoA activity, immunofluorescence for ARHGAP18/p62, scratch assay, pharmacological autophagy inhibition, human tissue staining |
Disease models & mechanisms |
Medium |
33973626
|
| 2021 |
The lncRNA HOTAIRM1 (controlled by AML1) represses ARHGAP18 expression by binding to its transcriptional inhibitory region and by sequestering the transcription factor AML1 from binding the ARHGAP18 regulatory region; HOTAIRM1-mediated ARHGAP18 suppression increases RhoA/ROCK1 signaling to promote glucocorticoid resistance in leukemia cells. |
ChIRP-seq, RNA interference, luciferase reporter, co-immunoprecipitation of HOTAIRM1-AML1, ChIP for AML1 at HOTAIRM1 promoter, ROCK1 inhibitor rescue |
Cell death & disease |
Medium |
34262023
|
| 2024 |
ARHGAP18 is localized by binding to active (phosphorylated) microvillar ezrin, and this interaction enhances ARHGAP18's RhoGAP activity; the ezrin-ARHGAP18 complex acts as a negative autoregulatory module to locally reduce RhoA activity in microvilli. Loss of ARHGAP18 causes aberrant assembly of myosin-2 filaments inside microvilli and disrupts the distinction between microvilli and the terminal web. |
Co-immunoprecipitation, in vitro RhoGAP activity assay with ezrin, CRISPR/Cas9 KO, immunofluorescence, structured illumination microscopy |
eLife |
High |
38193818
|
| 2025 |
ERK inhibits Ezrin activity in the cell body by phosphorylating the C-terminal tail of the Ezrin-activating kinase LOK; reduced Ezrin activity releases Ezrin's recruitment/activation of ARHGAP18, thereby de-repressing RhoA and enabling stress fiber assembly for cell migration. Thus ARHGAP18 operates downstream of an ERK-LOK-Ezrin axis. |
Phosphoproteomics, kinase assays, Ezrin/ARHGAP18 interaction studies, cell migration assays, RhoA activity measurements |
bioRxivpreprint |
Medium |
bio_10.1101_2025.11.15.688645
|
| 2025 |
ARHGAP18 forms a complex with the Hippo pathway transcription factor YAP; CRISPR/Cas9 KO of ARHGAP18 causes cytoskeletal alterations driven by both dysregulated RhoA signaling and aberrant nuclear localization of YAP, demonstrating coordinate regulation of the Hippo and Rho GTPase pathways through ARHGAP18. |
Co-immunoprecipitation of ARHGAP18-YAP complex, CRISPR/Cas9 KO, STORM super-resolution microscopy of actin filaments, immunofluorescence for YAP localization |
bioRxivpreprint |
Medium |
39651219
|
| 2010 |
ARHGAP18/SENEX regulates stress-induced premature senescence in endothelial cells through the p16(INK4a)/retinoblastoma protein pathway; SENEX depletion by siRNA causes endothelial apoptosis, indicating it is required for EC survival under H2O2-mediated stress. |
siRNA knockdown, H2O2 stress induction, senescence-associated β-galactosidase staining, apoptosis assays |
Blood |
Medium |
20664062
|
| 2017 |
Activation of the GnRH receptor in MDA-MB-231 breast cancer cells decreases ARHGAP18 expression, which correlates with increased cell adhesion and reduced tumor invasion, placing ARHGAP18 downstream of GnRHR signaling in regulation of cell invasiveness. |
Microarray gene expression, GnRHR activation, siRNA knockdown of ARHGAP18, cell adhesion and invasion assays |
Molecular and cellular endocrinology |
Low |
28709956
|
| 2023 |
Transcription factor GATA1 binds directly to the ARHGAP18 promoter and activates its transcription in hepatocellular carcinoma cells; GATA1 overexpression rescues the effects of ARHGAP18 silencing, defining GATA1 as an upstream transcriptional activator of ARHGAP18. |
Luciferase reporter assay, ChIP-qPCR, immunofluorescence, gain/loss-of-function rescue experiments |
Applied biochemistry and biotechnology |
Medium |
37171759
|